Literature DB >> 24036493

Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.

William B Rizzo1.   

Abstract

Normal fatty aldehyde and alcohol metabolism is essential for epidermal differentiation and function. Long-chain aldehydes are produced by catabolism of several lipids including fatty alcohols, sphingolipids, ether glycerolipids, isoprenoid alcohols and certain aliphatic lipids that undergo α- or ω-oxidation. The fatty aldehyde generated by these pathways is chiefly metabolized to fatty acid by fatty aldehyde dehydrogenase (FALDH, alternately known as ALDH3A2), which also functions to oxidize fatty alcohols as a component of the fatty alcohol:NAD oxidoreductase (FAO) enzyme complex. Genetic deficiency of FALDH/FAO in patients with Sjögren-Larsson syndrome (SLS) results in accumulation of fatty aldehydes, fatty alcohols and related lipids (ether glycerolipids, wax esters) in cultured keratinocytes. These biochemical changes are associated with abnormalities in formation of lamellar bodies in the stratum granulosum and impaired delivery of their precursor membranes to the stratum corneum (SC). The defective extracellular SC membranes are responsible for a leaky epidermal water barrier and ichthyosis. Although lamellar bodies appear to be the pathogenic target for abnormal fatty aldehyde/alcohol metabolism in SLS, the precise biochemical mechanisms are yet to be elucidated. Nevertheless, studies in SLS highlight the critical importance of FALDH and normal fatty aldehyde/alcohol metabolism for epidermal function. This article is part of a Special Issue entitled The Important Role of Lipids in the Epidermis and their Role in the Formation and Maintenance of the Cutaneous Barrier. Guest Editors: Kenneth R. Feingold and Peter Elias.
© 2013.

Entities:  

Keywords:  Epidermis; Ichthyosis; Lamellar body; Membrane; Sjögren–Larsson syndrome; Stratum corneum

Mesh:

Substances:

Year:  2013        PMID: 24036493      PMCID: PMC3993971          DOI: 10.1016/j.bbalip.2013.09.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  160 in total

1.  Defective inactivation of leukotriene B4 in patients with Sjögren-Larsson syndrome.

Authors:  M A Willemsen; J G de Jong; P H van Domburg; J J Rotteveel; R J Wanders; E Mayatepek
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

Review 2.  Barrier function of the skin: "la raison d'être" of the epidermis.

Authors:  Kathi C Madison
Journal:  J Invest Dermatol       Date:  2003-08       Impact factor: 8.551

3.  Phytanic acid in patients with Refsum's syndrome and response to dietary treatment.

Authors:  D Steinberg; C E Mize; J H Herndon; H M Fales; W K Engel; F Q Vroom
Journal:  Arch Intern Med       Date:  1970-01

Review 4.  Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment.

Authors:  V J Feron; H P Til; F de Vrijer; R A Woutersen; F R Cassee; P J van Bladeren
Journal:  Mutat Res       Date:  1991 Mar-Apr       Impact factor: 2.433

Review 5.  Sphingolipid signaling in epidermal homeostasis. Current knowledge and new therapeutic approaches in dermatology.

Authors:  C C Geilen; S Barz; M Bektas
Journal:  Skin Pharmacol Appl Skin Physiol       Date:  2001 Sep-Oct

6.  Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids.

Authors:  A Benedetti; M Comporti; H Esterbauer
Journal:  Biochim Biophys Acta       Date:  1980-11-07

7.  Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome.

Authors:  M A Willemsen; J J Rotteveel; J G de Jong; R J Wanders; L IJlst; G F Hoffmann; E Mayatepek
Journal:  J Neurol Sci       Date:  2001-01-15       Impact factor: 3.181

8.  omega-Hydroxyacid derivatives in the epidermis of several mammalian species.

Authors:  P W Wertz; D T Downing
Journal:  Comp Biochem Physiol B       Date:  1989

Review 9.  Differentiation of human keratinocytes requires the vitamin d receptor and its coactivators.

Authors:  Wendy B Bollag
Journal:  J Invest Dermatol       Date:  2007-04       Impact factor: 8.551

10.  Accumulation of 1-o-alkyl-2,3-diacylglycerols in cultured rat keratinocytes.

Authors:  H Oku; J Shudo; J Nagata; I Chinen
Journal:  Biochim Biophys Acta       Date:  1996-03-29
View more
  34 in total

1.  Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.

Authors:  Tatsuro Naganuma; Shuyu Takagi; Tsukasa Kanetake; Takuya Kitamura; Satoko Hattori; Tsuyoshi Miyakawa; Takayuki Sassa; Akio Kihara
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

2.  An overview of inborn errors of complex lipid biosynthesis and remodelling.

Authors:  Foudil Lamari; Fanny Mochel; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2014-09-20       Impact factor: 4.982

Review 3.  Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.

Authors:  Ana R Malheiro; Tiago Ferreira da Silva; Pedro Brites
Journal:  J Inherit Metab Dis       Date:  2014-11-29       Impact factor: 4.982

Review 4.  Cell adhesion in epidermal development and barrier formation.

Authors:  Kaelyn D Sumigray; Terry Lechler
Journal:  Curr Top Dev Biol       Date:  2015-02-11       Impact factor: 4.897

5.  Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome.

Authors:  Eveline Teresa Hidalgo; Cordelia Orillac; Andrew Hersh; David H Harter; William B Rizzo; Howard L Weiner
Journal:  J Child Neurol       Date:  2016-10-06       Impact factor: 1.987

Review 6.  The clinical spectrum of inherited diseases involved in the synthesis and remodeling of complex lipids. A tentative overview.

Authors:  Àngels Garcia-Cazorla; Fanny Mochel; Foudil Lamari; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2014-11-21       Impact factor: 4.982

Review 7.  S1P and plasmalogen derived fatty aldehydes in cellular signaling and functions.

Authors:  David L Ebenezer; Panfeng Fu; Ramaswamy Ramchandran; Alison W Ha; Vijay Putherickal; Tara Sudhadevi; Anantha Harijith; Fabian Schumacher; Burkhard Kleuser; Viswanathan Natarajan
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-03-12       Impact factor: 4.698

8.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

9.  1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.

Authors:  Dana S'aulis; Emily A Khoury; Morgan Zabel; William B Rizzo
Journal:  Mol Genet Metab       Date:  2020-08-12       Impact factor: 4.797

10.  Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome.

Authors:  Koki Nojiri; Shuhei Fudetani; Ayami Arai; Takuya Kitamura; Takayuki Sassa; Akio Kihara
Journal:  Mol Cell Biol       Date:  2021-08-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.